✦ LIBER ✦

A novel mechanism of factor VIII protection by von Willebrand factor from activated protein C-catalyzed inactivation

✍ Scribed by Nogami, K.

Book ID: 121680798
Publisher: American Society of Hematology
Year: 2002
Tongue: English
Weight: 188 KB
Volume: 99
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood.v99.11.3993

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-prothrombin IgG from patients with

Anti-prothrombin IgG from patients with anti-phospholipid antibodies inhibits the inactivation of factor Va by activated protein C

✍ Monica Galli; George M. Willems; Jan Rosing; Rita M. Janssen; José W. P. Govers- 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB

Albumin, fibrinogen, von Willebrand fact

Albumin, fibrinogen, von Willebrand factor, factor VIII activity, and leukocyte count are significant nontraditional risk factors for CHD in patients with diabetes: Plasma concentrations of C reactive protein and serum amyloid A protein are significant markers of future risk of coronary heart disease

✍ Gavin J. Blake; Paul M. Ridker 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Activation of demineralized bone matrix

Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein-2 with a collagen binding domain derived from von Willebrand factor propolypeptide

✍ Bing Chen; Hang Lin; Yannan Zhao; Bin Wang; Yanhong Zhao; Yunpeng Liu; Zhonghao 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 1 views

## Abstract There is a large demand for new bone regeneration to restore the function during bone injuries. Bone filling materials are important in bone tissue restoration. In this study, the demineralized bone matrix (DBM) was activated with the engineering human bone morphogenetic protein‐2 (BMP‐

A patient with von Willebrand's disease

A patient with von Willebrand's disease characterized by a compound heterozygosity for a substitution of Arg by Gln in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF allele

✍ Kathelijne Peerlinck; Jeroen C. J. Eikenboom; Hans K. Ploos; Van Amstel; Wanida 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 961 KB